Abstract
The intramuscular administration of the complex of tris(2-hydroxyethyl)amine with zinc bis[(2-methylphenoxy)acetate] (Zitrimin), as an aqueous solution in a dose of 10 mg (kg of animal weight)−1 for 2 months decreases activity of lysosomal lipolytic hydrolase (EC 3.1.1), cholesterol esterase (EC 3.1.1.13). Hence, the previously unknown feature of Zitrimin, that is, the ability to inhibit cholesterol esterase, attests to both structural and functional disorders of subcellular structures during development of atherosclerosis. The agents active towards such reactions can be useful in this case. Owing to the new properties, Zitrimin can be used to increase the vascular system stability to cholesterol during the atherosclerotic process. This expands the scope of applicability of this compound and gives prospects for development of new Zitrimin-based drugs for preventing the atherosclerotic vascular changes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
A. P. Vasil’ev, N. N. Strel’tsova, M. A. Sekisova, Klin. Meditsina [Clinical Medicine], 2009, 4, 37 (in Russian).
A. A. Pokrovskii, V. A. Tutel’yan, Lizosomy [Lysosomes], Nauka, Moscow, 1976, 380 pp. (in Russian).
H. Brokerhof, R. Jensen, Lipolytic Enzymes, Academic Press, New York, 1974, 320 pp.
A. V. Efremov, L. A. Ruyatkina, O. V. Tsygankova, Z. G. Bondareva, Patolog. Fiziologiya Eksperim. Terapiya [Pathological Physiology and Experimental Therapy], 2007, No. 1, 18 (in Russian).
O. V. Tsygankova, L. A. Ruyatkina, Z. G. Bondareva, Tsitokiny i Vospalenie [Cytokines and Inflammation], 2009, 8, No. 4, 17 (in Russian).
V. T. Tadiboyina, D. M. Liu, B. A. Miskie, J. Wang, R. A. Hegele, Lipids Health Dis., 2005, 4, 26.
A. V. Vasil’ev, S. N. Bogdanova, E. A. Varsanovich, A. V. Pogozheva, M. A. Samsonov, Voprosy Med. Khim. [Med. Chem. Issues], 1992, 38, No. 5, 50 (in Russian).
F. Hucho, Neurochemistry, Fundamentals and Concepts, Eds M. Bijo, Th. Parambi, Della Grace, Springer, 1987, p. 29.
M. G. Voronkov, S. N. Adamovich, R. G. Mirskov, A. N. Mirskova, Russ. J. Gen. Chem., 2009, 79, 159.
M. M. Rasulov, K. A. Abzaeva, M. I. Yakhkind, I. V. Zhigacheva, I. S. Nikolaeva, R. M. Rasulov, M. G. Voronkov, Russ. Chem. Bull., 2015, 64, 1682.
M. Rasulov, P. Storozhenko, I. Zhigacheva, Alkankarbonovye kisloty i ikh proizvodnye v biologii i meditsine [Alkanecarboxylic Acids and Their Derivatives in Biology and Medicine], Palmarium Academic Publishing, Saarbrucken, 2018, 236 pp.
M. M. Rasulov, M. V. Zvereva, M. K. Nurbekov, S. N. Adamovich, A. N. Mirskova, R. G. Mirskov, M. G. Voronkov, RF Pat. No. 2457837 (C1), Byul. izobret. [Invent. Bull.], 2012, No. 22 (in Russian).
M. G. Voronkov, G. A. Kuznetsova, A. Yu. Fedorin, G. G. Yushkov, A. V. Mashanov, N. A. Malyshkina, M. M. Rasulov, RF Pat. No. 2418580 (C1), Byul. izobret. [Invent. Bull.], 2011, No. 14 (in Russian).
N. N. Anichkov, Arkhiv Biol. Nauk [Biol. Sci. Archive], 1937, 48, 119 (in Russian).
N. Haley, S. Fowler, C. De Duve, J. Lipid. Res., 1980, 8, 961.
V. V. Men’shikov, Laboratornye metody issledovaniya v klinike [Laboratory Investigation Methods in Clinics], Meditsina, Moscow, 1987, 106 pp. (in Russian).
W. Friedewald, R. Levy, D. Fredrickson, Clin. Chem., 1972, 18, 499.
M. M. Rasulov, S. N. Bobkova, O. A. Belikova, M. K. Nurbekov, M. G. Voronkov, RF Pat. No. 2444357 (C1), Byul. izobret. [Invent. Bull.], 2012, No. 7 (in Russian).
Yu. N. Tyurin, A. A. Makarov, Analiz dannykh na komp’yutere [Computer Data Analysis], Finansy i statistika, Moscow, 1995, 384 pp. (in Russian).
R. R. Packard, P. Libby, Clin. Chem., 2008, 54, 24.
P. K. Anokhin, Biologiya i neirofiziologiya uslovnogo refleksa [Biology and Neurophysiology of the Conditioned Reflex], Meditsina, Moscow, 1968, 507 pp. (in Russian).
M. M. Rasulov, Printsipial’nye voprosy teorii funktsional’nykh sistem P. K. Anokhina [Key Issues of P. K. Anokhin’s Theory of Functional Systems], MGPU, Moscow, 2005, 42 pp. (in Russian).
M. M. Rasulov, M. K. Nurbekov, M. G. Voronkov, S. N. Bobkova, O. A Belikova, I. G. Kizlikov, RF Pat. No. 2429832 (C1), Byul. izobret. [Invent. Bull.], 2011, No. 27 (in Russian).
A. P. Rachin, R. M. Rasulov, P. A. Storozhenko, M. M. Rasulov, K. A. Abzaeva, I. V. Zhigacheva, RF Pat. No. 2706715 (C1), Byul. izobret. [Invent. Bull.], 2019, No. 32 (in Russian).
K. A. Abzaeva, M. M. Rasulov, I. V. Zhigacheva, Russ. Chem. Bull., 2019, 68, 1122.
V. S. Gurevich, S. A. Urazgel’dieva, M. I. Bukhtashvili, L. V. Vasina, Ateroskleroz i dislipidemii [Atherosclerosis and Dyslipidemias], 2012, No. 4, 55 (in Russian).
Author information
Authors and Affiliations
Corresponding authors
Additional information
Published in Russian in Izvestiya Akademii Nauk. Seriya Khimicheskaya, No. 7, pp. 1404–1407, July, 2021.
This paper does not contain descriptions of studies on animals or humans.
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Storozhenko, P.A., Zhigacheva, I.V. & Rasulov, M.M. Complex of tris(2-hydroxyethyl)amine with zinc bis[(2-methylphenoxy)acetate] as an aortic cholesterol esterase inhibitor in the experiment. Russ Chem Bull 70, 1404–1407 (2021). https://doi.org/10.1007/s11172-021-3231-2
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11172-021-3231-2